Daniel Vitt - Feb 26, 2024 Form 4 Insider Report for IMMUNIC, INC. (IMUX)

Role: President and CEO, Director
Signature: /s/ Daniel Vitt
Stock symbol: IMUX
Transactions as of: Feb 26, 2024
Transactions value $: $18,333
Form type: 4
Date filed: 2/28/2024, 05:19 PM
Previous filing: Jan 19, 2024
Next filing: Mar 6, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMUX	Common Stock	Purchase	$18.3K	+14K	+3.71%	$1.31	391K	Feb 26, 2024	See footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	14,000 shares of Immunic, Inc. common stock are owned directly by the Reporting Person, and 362,877 shares of Immunic, Inc. common stock are owned by Listrax UG (haftungsbeschrankt). The Reporting Person is Managing Director of Listrax UG and exercises voting and dispositive power over such shares. The spouse of the Reporting Person acquired 14,000 shares of Immunic, Inc. common stock on February 26, 2024.

Content

14,000 shares of Immunic, Inc. common stock are owned directly by the Reporting Person, and 362,877 shares of Immunic, Inc. common stock are owned by Listrax UG (haftungsbeschrankt). The Reporting Person is Managing Director of Listrax UG and exercises voting and dispositive power over such shares. The spouse of the Reporting Person acquired 14,000 shares of Immunic, Inc. common stock on February 26, 2024.